{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:11:02Z","timestamp":1792782662960,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202210"],"award-info":[{"award-number":["82202210"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101994"],"award-info":[{"award-number":["82101994"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515012725"],"award-info":[{"award-number":["2023A1515012725"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Science and Technology Program of Guangzhou","award":["202206010046"],"award-info":[{"award-number":["202206010046"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00259-024-06622-z","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T03:03:05Z","timestamp":1706756585000},"page":"1989-2001","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Head-to-head comparison between [68Ga]Ga-DOTA-NOC and [18F]DOPA PET\/CT in a diverse cohort of patients with pheochromocytomas and paragangliomas"],"prefix":"10.1007","volume":"51","author":[{"given":"Qiao","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengkun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3441-5194","authenticated-orcid":false,"given":"Xiangsong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"key":"6622_CR1","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1245\/s10434-013-2942-5","volume":"20","author":"L Fishbein","year":"2013","unstructured":"Fishbein L, Merrill S, Fraker DL, Cohen DL, Nathanson KL. Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing. Ann Surg Oncol. 2013;20:1444\u201350. https:\/\/doi.org\/10.1245\/s10434-013-2942-5.","journal-title":"Ann Surg Oncol"},{"key":"6622_CR2","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s12094-021-02622-9","volume":"23","author":"R Garcia-Carbonero","year":"2021","unstructured":"Garcia-Carbonero R, Matute Teresa F, Mercader-Cidoncha E, Mitjavila-Casanovas M, Robledo M, Tena I, et al. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas. Clin Transl Oncol. 2021;23:1995\u20132019. https:\/\/doi.org\/10.1007\/s12094-021-02622-9.","journal-title":"Clin Transl Oncol"},{"key":"6622_CR3","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:1915\u201342. https:\/\/doi.org\/10.1210\/jc.2014-1498.","journal-title":"J Clin Endocrinol Metab"},{"key":"6622_CR4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/MPA.0000000000001792","volume":"50","author":"L Fishbein","year":"2021","unstructured":"Fishbein L, Del Rivero J, Else T, Howe JR, Asa SL, Cohen DL, et al. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and\/or Unresectable Pheochromocytoma and Paraganglioma. Pancreas. 2021;50:469\u201393. https:\/\/doi.org\/10.1097\/MPA.0000000000001792.","journal-title":"Pancreas"},{"key":"6622_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.2214\/AJR.12.9126","volume":"200","author":"K Leung","year":"2013","unstructured":"Leung K, Stamm M, Raja A, Low G. Pheochromocytoma: the range of appearances on ultrasound, CT, MRI, and functional imaging. AJR Am J Roentgenol. 2013;200:370\u20138. https:\/\/doi.org\/10.2214\/AJR.12.9126.","journal-title":"AJR Am J Roentgenol"},{"key":"6622_CR6","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.3174\/ajnr.A7266","volume":"42","author":"Y Ota","year":"2021","unstructured":"Ota Y, Liao E, Capizzano AA, Kurokawa R, Bapuraj JR, Syed F, et al. Diagnostic role of diffusion-weighted and dynamic contrast-enhanced perfusion MR imaging in paragangliomas and schwannomas in the head and neck. AJNR Am J Neuroradiol. 2021;42:1839\u201346. https:\/\/doi.org\/10.3174\/ajnr.A7266.","journal-title":"AJNR Am J Neuroradiol"},{"key":"6622_CR7","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00259-016-3605-0","volume":"44","author":"C Heimburger","year":"2017","unstructured":"Heimburger C, Veillon F, Ta\u00efeb D, Goichot B, Riehm S, Petit-Thomas J, et al. Head-to-head comparison between 18F-FDOPA PET\/CT and MR\/CT angiography in clinically recurrent head and neck paragangliomas. Eur J Nucl Med Mol Imaging. 2017;44:979\u201387. https:\/\/doi.org\/10.1007\/s00259-016-3605-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1\u20132","key":"6622_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10354-018-0658-7","volume":"169","author":"AS Kroiss","year":"2019","unstructured":"Kroiss AS. Current status of functional imaging in neuroblastoma, pheochromocytoma, and paraganglioma disease. Wien Med Wochenschr. 2019;169(1\u20132):25\u201332. https:\/\/doi.org\/10.1007\/s10354-018-0658-7.","journal-title":"Wien Med Wochenschr"},{"key":"6622_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1259\/bjr\/23668769","volume":"77","author":"K Zaplatnikov","year":"2004","unstructured":"Zaplatnikov K, Menzel C, D\u00f6bert N, Hamscho N, Kranert WT, Gotthard M, et al. Case report: drug interference with MIBG uptake in a patient with metastatic paraganglioma. Br J Radiol. 2004;77:525\u20137. https:\/\/doi.org\/10.1259\/bjr\/23668769.","journal-title":"Br J Radiol"},{"key":"6622_CR10","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1080\/11024150152717733","volume":"167","author":"K Taniguchi","year":"2001","unstructured":"Taniguchi K, Ishizu K, Torizuka T, Hasegawa S, Okawada T, Ozawa T, et al. Metastases of predominantly dopamine-secreting phaeochromocytoma that did not accumulate metaiodobenzylguanidine: imaging with whole body positron emission tomography using 18F-labelled deoxyglucose. Eur J Surg. 2001;167:866\u201370. https:\/\/doi.org\/10.1080\/11024150152717733.","journal-title":"Eur J Surg"},{"key":"6622_CR11","first-page":"122","volume":"57","author":"V Rufini","year":"2013","unstructured":"Rufini V, Treglia G, Castaldi P, Perotti G, Giordano A. Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review. Q J Nucl Med Mol Imaging. 2013;57:122\u201333.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"6622_CR12","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s00259-004-1697-4","volume":"32","author":"D Wild","year":"2005","unstructured":"Wild D, M\u00e4cke HR, Waser B, Reubi JC, Ginj M, Rasch H, et al. 68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5. Eur J Nucl Med Mol Imaging. 2005;32:724. https:\/\/doi.org\/10.1007\/s00259-004-1697-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6622_CR13","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1007\/s00259-012-2119-7","volume":"39","author":"JB Maurice","year":"2012","unstructured":"Maurice JB, Troke R, Win Z, Ramachandran R, Al-Nahhas A, Naji M, et al. A comparison of the performance of 68Ga-DOTATATE PET\/CT and 123I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2012;39:1266\u201370. https:\/\/doi.org\/10.1007\/s00259-012-2119-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6622_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1148\/radiol.2222010622","volume":"222","author":"S Hoegerle","year":"2002","unstructured":"Hoegerle S, Nitzsche E, Altehoefer C, Ghanem N, Manz T, Brink I, et al. Pheochromocytomas: detection with 18F-DOPA whole body PET\u2013initial results. Radiology. 2002;222:507\u201312. https:\/\/doi.org\/10.1148\/radiol.2222010622.","journal-title":"Radiology"},{"key":"6622_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2967\/jnumed.108.058396","volume":"50","author":"F Imani","year":"2009","unstructured":"Imani F, Agopian VG, Auerbach MS, Walter MA, Imani F, Benz MR, et al. 18F-FDOPA PET and PET\/CT accurately localize pheochromocytomas. J Nucl Med. 2009;50:513\u20139. https:\/\/doi.org\/10.2967\/jnumed.108.058396.","journal-title":"J Nucl Med"},{"key":"6622_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/cen.12126","volume":"79","author":"S Gabriel","year":"2013","unstructured":"Gabriel S, Blanchet EM, Sebag F, Chen CC, Fakhry N, Deveze A, et al. Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions. Clin Endocrinol (Oxf). 2013;79:170\u20137. https:\/\/doi.org\/10.1111\/cen.12126.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"6622_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/RLU.0000000000000242","volume":"39","author":"A Bacca","year":"2014","unstructured":"Bacca A, Chiacchio S, Zampa V, Carrara D, Duce V, Congregati C, et al. Role of 18F-DOPA PET\/CT in diagnosis and follow-up of adrenal and extra-adrenal paragangliomas. Clin Nucl Med. 2014;39:14\u201320. https:\/\/doi.org\/10.1097\/RLU.0000000000000242.","journal-title":"Clin Nucl Med"},{"key":"6622_CR18","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00259-013-2598-1","volume":"41","author":"P Sharma","year":"2014","unstructured":"Sharma P, Dhull VS, Arora S, Gupta P, Kumar R, Durgapal P, et al. Diagnostic accuracy of (68)Ga-DOTANOC PET\/CT imaging in pheochromocytoma. Eur J Nucl Med Mol Imaging. 2014;41:494\u2013504. https:\/\/doi.org\/10.1007\/s00259-013-2598-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"40","key":"6622_CR19","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1007\/s00259-013-2548-y","volume":"I","author":"A Kroiss","year":"2013","unstructured":"Kroiss A, Putzer D, Frech A, Decristoforo C, Uprimny C, Gasser RW, et al. A retrospective comparison between 68Ga-DOTA-TOC PET\/CT and 18F-DOPA PET\/CT in patients with extra-adrenal paraganglioma. Eur J Nucl Med Mol. 2013;I(40):1800\u20138. https:\/\/doi.org\/10.1007\/s00259-013-2548-y.","journal-title":"Eur J Nucl Med Mol"},{"key":"6622_CR20","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1158\/1078-0432.CCR-14-2751","volume":"21","author":"I Janssen","year":"2015","unstructured":"Janssen I, Blanchet EM, Adams K, Chen CC, Millo CM, Herscovitch P, et al. Superiority of [68Ga]-DOTATATE PET\/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma. Clin Cancer Res. 2015;21:3888\u201395. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-2751.","journal-title":"Clin Cancer Res"},{"issue":"43","key":"6622_CR21","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1007\/s00259-015-3268-2","volume":"I","author":"A Archier","year":"2016","unstructured":"Archier A, Varoquaux A, Garrigue P, Montava M, Guerin C, Gabriel S, et al. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET\/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases. Eur J Nucl Med Mol. 2016;I(43):1248\u201357. https:\/\/doi.org\/10.1007\/s00259-015-3268-2.","journal-title":"Eur J Nucl Med Mol"},{"issue":"43","key":"6622_CR22","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1007\/s00259-016-3357-x","volume":"I","author":"I Janssen","year":"2016","unstructured":"Janssen I, Chen CC, Millo CM, Ling A, Taieb D, Lin FI, et al. PET\/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT\/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma. Eur J Nucl Med Mol. 2016;I(43):1784\u201391. https:\/\/doi.org\/10.1007\/s00259-016-3357-x.","journal-title":"Eur J Nucl Med Mol"},{"key":"6622_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2967\/jnumed.115.161018","volume":"57","author":"I Janssen","year":"2016","unstructured":"Janssen I, Chen CC, Taieb D, Patronas NJ, Millo CM, Adams KT, et al. 68Ga-DOTATATE PET\/CT in the localization of head and neck paragangliomas compared with other functional imaging modalities and CT\/MRI. J Nucl Med. 2016;57:186\u201391. https:\/\/doi.org\/10.2967\/jnumed.115.161018.","journal-title":"J Nucl Med"},{"key":"6622_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.nucmedbio.2019.04.003","volume":"71","author":"AS Kroiss","year":"2019","unstructured":"Kroiss AS, Uprimny C, Shulkin BL, Gruber L, Frech A, Url C, et al. 68Ga-DOTATOC PET\/CT in the localization of head and neck paraganglioma compared with 18F-DOPA PET\/CT and 123I-MIBG SPECT\/CT. Nucl Med Biol. 2019;71:47\u201353. https:\/\/doi.org\/10.1016\/j.nucmedbio.2019.04.003.","journal-title":"Nucl Med Biol"},{"key":"6622_CR25","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1210\/jcem.74.5.1349024","volume":"74","author":"JC Reubi","year":"1992","unstructured":"Reubi JC, Waser B, Khosla S, Kvols L, Goellner JR, Krenning E, et al. In vitro and in vivo detection of somatostatin receptors in pheochromocytomas and paragangliomas. J Clin Endocrinol Metab. 1992;74:1082\u20139. https:\/\/doi.org\/10.1210\/jcem.74.5.1349024.","journal-title":"J Clin Endocrinol Metab"},{"key":"6622_CR26","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s13139-015-0356-y","volume":"49","author":"I Lee","year":"2015","unstructured":"Lee I, Paeng JC, Lee SJ, Shin CS, Jang JY, Cheon GJ, et al. Comparison of diagnostic sensitivity and quantitative indices between (68)Ga-DOTATOC PET\/CT and (111)in-pentetreotide SPECT\/CT in neuroendocrine tumors: a preliminary report. Nucl Med Mol Imaging. 2015;49:284\u201390. https:\/\/doi.org\/10.1007\/s13139-015-0356-y.","journal-title":"Nucl Med Mol Imaging"},{"issue":"3","key":"6622_CR27","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1007\/s00330-015-3882-1","volume":"26","author":"S Van Binnebeek","year":"2016","unstructured":"Van Binnebeek S, Vanbilloen B, Baete K, Terwinghe C, Koole M, Mottaghy FM, et al. Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET\/CT: a lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours. Eur Radiol. 2016;26(3):900\u20139. https:\/\/doi.org\/10.1007\/s00330-015-3882-1.","journal-title":"Eur Radiol"},{"issue":"12","key":"6622_CR28","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1210\/jc.2009-1248","volume":"94","author":"HJ Timmers","year":"2009","unstructured":"Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Havekes B, Eisenhofer G, Martiniova L, Adams KT, Pacak K. Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2009;94(12):4757\u201367. https:\/\/doi.org\/10.1210\/jc.2009-1248.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"6622_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.remn.2018.09.004","volume":"38","author":"AS Kroiss","year":"2019","unstructured":"Kroiss AS, Uprimny C, Shulkin BL, Gruber L, Frech A, Jazbec T, et al. 68Ga-DOTATOC PET\/CT in the localization of metastatic extra-adrenal paraganglioma and pheochromocytoma compared with 18F-DOPA PET\/CT. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2019;38(2):94\u20139. https:\/\/doi.org\/10.1016\/j.remn.2018.09.004.","journal-title":"Rev Esp Med Nucl Imagen Mol (Engl Ed)"},{"issue":"44","key":"6622_CR30","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s00259-016-3586-z","volume":"I","author":"CC Feral","year":"2017","unstructured":"Feral CC, Tissot FS, Tosello L, Fakhry N, Sebag F, Pacak K, et al. 18F-fluorodihydroxyphenylalanine PET\/CT in pheochromocytoma and paraganglioma: relation to genotype and amino acid transport system L. Eur J Nucl Med Mol. 2017;I(44):812\u201321. https:\/\/doi.org\/10.1007\/s00259-016-3586-z.","journal-title":"Eur J Nucl Med Mol"},{"key":"6622_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.humpath.2018.11.020","volume":"86","author":"H Leijon","year":"2019","unstructured":"Leijon H, Remes S, Hagstr\u00f6m J, Louhimo J, M\u00e4enp\u00e4\u00e4 H, Schalin-J\u00e4ntti C, et al. Variable somatostatin receptor subtype expression in 151 primary pheochromocytomas and paragangliomas. Hum Pathol. 2019;86:66\u201375. https:\/\/doi.org\/10.1016\/j.humpath.2018.11.020.","journal-title":"Hum Pathol"},{"issue":"9","key":"6622_CR32","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.2967\/jnumed.111.101303","volume":"53","author":"HC Rischke","year":"2012","unstructured":"Rischke HC, Benz MR, Wild D, Mix M, Dumont RA, Campbell D, et al. Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PET. J Nucl Med. 2012;53(9):1352\u20138. https:\/\/doi.org\/10.2967\/jnumed.111.101303.","journal-title":"J Nucl Med"},{"issue":"5","key":"6622_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s13139-023-00810-9","volume":"57","author":"SA Shamim","year":"2023","unstructured":"Shamim SA, Arora G, Kumar N, Hussain J, Gupta SD, St AR, et al. 68Ga-DOTANOC PET\/CT for Screening and Surveillance of Von Hippel-Lindau (VHL) disease. Nucl Med Mol Imaging. 2023;57(5):235\u201342. https:\/\/doi.org\/10.1007\/s13139-023-00810-9.","journal-title":"Nucl Med Mol Imaging"},{"issue":"10","key":"6622_CR34","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","volume":"46","author":"D Ta\u00efeb","year":"2019","unstructured":"Ta\u00efeb D, Hicks RJ, Hindi\u00e9 E, Guillet BA, Avram A, Ghedini P, et al. European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol I. 2019;46(10):2112\u201337. https:\/\/doi.org\/10.1007\/s00259-019-04398-1.","journal-title":"Eur J Nucl Med Mol I"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-06622-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-024-06622-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-06622-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T06:03:14Z","timestamp":1717048994000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-024-06622-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["6622"],"URL":"https:\/\/doi.org\/10.1007\/s00259-024-06622-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]},"assertion":[{"value":"19 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the First Affiliated Houspital of Sun Yat-sen University (ethics committee approval No. [2023]809).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The requirement for formal consent was waived by the approving ethics committee due to the retrospective nature of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}